表紙
市場調査レポート

欧州諸国(フランス・ドイツ・イタリア・スペイン・英国)の分子診断市場

2016-2020 EU5 Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

発行 Venture Planning Group 商品コード 233420
出版日 ページ情報 英文 1273 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。

Local License: 同一事業所内

Back to Top
欧州諸国(フランス・ドイツ・イタリア・スペイン・英国)の分子診断市場 2016-2020 EU5 Molecular Diagnostics Market: Supplier Shares, Country Volume and Sales Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
出版日: ページ情報: 英文 1273 Pages
概要

当レポートでは、欧州の主要5カ国(フランス・ドイツ・イタリア・スペイン・英国)における分子診断市場の最新動向と将来展望について分析し、検査技術の研究開発の最新動向、各国市場の基本構造・動向、今後5年間の市場動向予測、市場拡大のための戦略と課題、主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界市場と技術概要

  • DNAシーケンシング
    • イントロダクション
    • シーケンシング手法
    • オートラジオグラフィー
    • ヒトゲノムプロジェクト
    • シーケンシングの自動化
    • イメージスキャナ
    • 蛍光検出
    • 遺伝子プロファイリング
    • 遺伝子発現
    • 遺伝子多型
    • タンパク質間相互作用ネットワークk
  • DNAおよびRNAプローブ技術
    • 基本的原則
    • プローブの分離
    • DNAプローブ検査
    • 検査フォーマット
    • 標識技術
    • 増幅手法
  • 検出技術
    • 放射線による手法
    • 非アイソトープ式手法
  • 装置レビュー
    • Abbott LCx
    • Beckman Coulter/Biomek FK
    • Becton Dickinson SDA
    • Bio-Rad GeneScope
    • Gen-Probe Tigris
    • Roche Cobas Amplicor
    • Tecan LS Series
  • バイオチップ:ゲノセンサー、マイクロアレイ、ラボオンチップ
    • 液体輸送・混合
    • 分離
    • 反応
    • 検知
  • ファーマコゲノミクス
  • 主な応用分野
    • 微生物/感染症
    • がん検査
    • 遺伝子疾患
    • 法医学検査
    • 実父確定検査/HLA型決定
    • その他の応用分野
  • 競合/補完技術
    • モノクローナル抗体/免疫検定
    • RNAプローブ
    • 二次元電気泳動
    • フローサイトメトリー

フランス市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

ドイツ市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

イタリア市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

スペイン市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

英国市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの売上高・市場シェア

主な製品開発機会

  • 機器
  • 試薬キットおよび検査システム/パネル
  • コンピューター・ソフトウェア・オートメーション
  • 補助製品

分散型検査製品の設計基準

代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業プロファイル

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

付録

  • 付録I:主な大学・研究機関
  • 付録II:用語集
  • 付録III:現在の為替レート

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD18283

This new 1,273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.

Contains: 1,273 pages and 139 tables.

Table of Contents

I. Introduction

II. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies For Decentralized Testing Markets

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge And Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Market and Technology Review

  • A. DNA Sequencing
    • 1. Introduction
    • 2. Sequencing Methods
    • 3. Autoradiography
    • 4. The Human Genome Project
    • 5. Sequencing Automation
    • 6. Image Scanners
    • 7. Fluorescent Detection
    • 8. Gene Profiling
    • 9. Gene Expression
    • 10. Polymorphism Screening
    • 11. Protein Interaction Networks
  • B. DNA and RNA Probe Technologies
    • 1. Basic Principles
    • 2. Probe Preparation
    • 3. The DNA Probe Test
    • 4. Test Formats
    • 5. Labeling Techniques
    • 6. Amplification Methods
  • C. Detection Technologies
    • 1. Radioactive Methods
      • a. Overview
      • b. Major Isotopes
        • P-32
        • S-35
        • H-3
        • I-125
    • 2. Non-Isotopic Methods
      • a. Enzymatic Labels
      • b. Chemical Labeling
        • Indirect Chemical Labeling
        • Direct Chemical Labeling
      • c. Fluorescence
      • d. Chemiluminescence
      • e. Electrical Conductivity
  • D. Molecular Diagnostic Instrumentation Review
    • 1. Abbott LCx
    • 2. Beckman Coulter/Biomek FK
    • 3. BD Viper System with XTR Technology
    • 4. BD Innova
    • 5. Becton Dickinson SDA
    • 6. bioMerieux NucliSENS easyMAG
    • 7. bioMerieux NucliSENS easyQ and MiniMAG
    • 8. Bio-Rad GeneScope
    • 9. Cepheid GeneXpert
    • 10. Curetis Unyvero
    • 11. GenMark Dx eSensor XT-8
    • 12. Hologic/Gen-Probe Panther
    • 13. Hologic/Gen-Probe Tigris/DTS
    • 14. HTG Molecular Edge
    • 15. Life Technologies QuantStudio Dx
    • 16. Qiagen QIAsymphony RGQ
    • 17. Roche Cobas Amplicor
    • 18. Roche Cobas TaqMan 48
    • 19. Roche Cobas TaqMan
    • 20. Roche Cobas TaqMan AmpliPrep
    • 21. Roche LighCycler 480
    • 22. Roche Cobas 4800
    • 23. Roche Cobas s 201
    • 24. Siemens Versant
    • 25. Tecan LS Series
  • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    • Liquid Transportation and Mixing
    • Separation
    • Reaction
    • Detection
  • F. Pharmacogenomics
  • G. Major Applications
    • 1. Microbiology/Infectious Diseases
      • a. Overview
      • b. Major Infectious Diseases
        • AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
        • Adenovirus
        • Aeromonas
        • Anthrax/Bacillus Anthracis
        • Arboviruses
        • Babesiosis
        • Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
        • Blastocystis Hominis
        • Brucella
        • Campylobacter
        • Candida
        • Chagas Disease
        • Chancroid
        • Chlamydia
        • Clostridium Difficile
        • Coronaviruses
        • Coxsackieviruses
        • Creutzfeldt-Jakob's Disease
        • Cryptosporidium Parvum
        • Cyclospora Cayetanensis
        • Cytomegalovirus
        • Ebola Virus
        • E. Coli
        • EchoVirus
        • Encephalitis
        • Enteroviruses
        • Epstein-Barr Virus
        • Giardia Lamblia
        • Gonorrhea
        • Granuloma Inguinale
        • Hantavirus
        • Helicobacter Pylori
        • Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
        • Herpes Simplex Virus
        • Human Herpes Virus-6 (HHV-6)
        • Influenza Viruses
        • Legionella
        • Lyme Disease
        • Lymphogranuloma Venereum (LGV)
        • Malaria
        • Measles (Rubeola)
        • Meningitis
        • Microsporidium
        • Mononucleosis
        • Mumps
        • Mycoplasma
        • Papillomaviruses
        • Parvovirus B19
        • Pneumonia
        • Polyomaviruses
        • Pseudomonas Aeruginosa
        • Rabies
        • Respiratory Syncytial Virus (RSV)
        • Rhinoviruses
        • Rotavirus
        • Rubella
        • Salmonellosis
        • Septicemia
        • Shigellosis
        • Staphylococcus Aureus
        • Streptococci
        • Syphilis
        • Toxoplasmosis
        • Trichomonas Vaginalis
        • Tuberculosis
        • Vibrio
        • West Nile Virus
        • Yersina
    • 2. Cancer Testing
      • a. Overview
      • b. Major Cancer Types
        • Prostate
        • Lung
        • Colon and Rectum
        • Breast
        • Skin
        • Uterine
        • Leukemia
        • Oral
      • c. Oncogenes
        • Abl/abl-bcr
        • AIB1
        • BCL-2
        • BRCA1
        • CD44
        • C-fos
        • C-myb
        • C-myc
        • CYP17
        • Erb-B
        • HPC1
        • N-myc
        • P40
        • P51
        • P53
        • PIK3CA
        • PTI-1
        • Ras
        • Reg
        • Sis
        • Src
    • 3. Genetic Diseases
      • a. Overview
      • b. Nucleic Acid Amplification
      • c. Chromosome Imaging
      • d. Genomics Technologies
      • e. Proteomics Technologies
      • f. Current Pharmacogenomic Tests
      • g. Future Pharmacogenomic Testing
      • h. Major Diseases
        • Achondroplasia
        • Autosomal Dominant Polycystic Kidney Disease
        • Cancer
        • Cosmetogenomics
        • Cystic Fibrosis
        • Down's Syndrome
        • Duchenne and Becker Muscular Dystrophy
        • Factor V (Leiden)
        • Factor IX Deficiency
        • Fragile X Syndrome
        • Heart Disease
        • Hemochomatosis
        • Hemophilia
        • Huntington's Disease
        • Maternal-Fetal Incompatibility
        • Multiple Endocrine Neoplasia
        • Phenylketonuria (PKU)
        • Polycystic Kidney Disease (PKD)
        • Prenatal Screening
        • Retinitis Pigmentosa
        • Retinoblastoma
        • Sickle Cell Anemia
        • Spinal Muscular Atrophy
        • Vitamin B12 Metabolism
      • i. Social Issues and Concerns
    • 4. Forensic Testing
      • a. Overview
      • b. Multilocus and Single Locus Probes
        • Multilocus Probes
        • Single Locus Probes
        • PCR and RFLP
      • c. The FBI
      • d. DNA Profile Data Banks
        • U.S.A.
        • U.K.
      • e. Judicial Implementation
      • f. Major Crime Categories
      • g. Factors Contributing to the DNA Probe Market Expansion
        • Technology Availability
        • Use of Hair as Evidence
      • h. Wildlife Forensics
    • 5. Paternity Testing/HLA Typing
    • 6. Other Applications
      • a. Disease Susceptibility Testing
      • b. Cardiovascular Diseases
      • c. Diabetes
      • d. Alzheimer's Disease
      • e. Periodontal Disease
      • f. Plasma Purification
      • g. Organ Transplantation
      • h. Water Contamination
      • i. Other
  • H. Competing/complementing
    • 1. Monoclonal Antibodies/Immunoassays
    • 2. RNA Probes
    • 3. Two-Dimensional Electrophoresis
    • 4. Flow Cytometry

VII. France Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

VIII. Germany Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

IX. Italy Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

X. Spain Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XI. U.K. Molecular Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares

XII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Cepheid
  • CellMark Forensics/LabCorp
  • Decode Genetics
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Li-Cor Biosciences
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher

XIII. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Bartonella
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Campylobacter
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Candida
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Chlamydia
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Clostridium
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Coronavirus
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Cryptosporidium
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing CMV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Echovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Enterovirus Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular
  • Diagnostic and Other Direct Identification Tests
  • Major Companies Developing or Marketing Giardia
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Gonorrhea
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Hantavirus
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Helicobacter
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Hepatitis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Herpes
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Influenza
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Legionella
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Lyme
  • Disease Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Measles
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Meningitis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Mononucleosis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Mumps
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Mycoplasma
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Pneumonia
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing RSV
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Rotavirus
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Rubella
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Salmonella
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Septicemia
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Shigella
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Streptococci
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Syphilis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Trichomonas
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Major Companies Developing or Marketing Tuberculosis
  • Molecular Diagnostic and Other Direct
  • Identification Tests
  • Oncogenes Potential Application in Cancer Diagnosis
  • Major Companies Developing or Marketing Cancer
  • Molecular Diagnostic Tests
  • Major Companies Developing or Marketing Molecular
  • Diagnostic Tests For Genetic Diseases
  • France
  • Molecular Diagnostics Test Volume And Sales
  • By Major Application
  • France
  • Laboratories Performing DNA Sequencing
  • By Market Segment
  • France
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • France
  • Molecular Diagnostics Test Volume
  • By Major Application
  • France
  • Major Infectious Disease Test Volume by Assay
  • France
  • Major Infectious Disease Test Volume by Method
  • France
  • Molecular Diagnostics Market
  • By Major Application
  • France
  • Molecular Diagnostics Market
  • Estimated Sales And Market Shares of Major Suppliers
  • France
  • Major Infectious Disease Diagnostics Market by Assay
  • France
  • AIDS Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Adenovirus Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Chlamydia Testing Market
  • Estimated Sales by Major Supplier
  • France
  • CMV Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Gonorrhea Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Hepatitis Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Hepatitis C Testing Market
  • Estimated Sales by Major Supplier
  • France
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • France
  • Herpes Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Influenza Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Meningitis Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • France
  • RSV Testing Market
  • Estimated Sales by Major Supplier
  • France
  • Shigella Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Molecular Diagnostics Test Volume And Sales
  • By Major Application
  • Germany
  • Laboratories Performing DNA Sequencing
  • By Market Segment
  • Germany
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Germany
  • Molecular Diagnostics Test Volume
  • By Major Application
  • Germany
  • Major Infectious Disease Test Volume by Assay
  • Germany
  • Major Infectious Disease Test Volume by Method
  • Germany
  • Molecular Diagnostics Market
  • By Major Application
  • Germany
  • Molecular Diagnostics Market
  • Estimated Sales And Market Shares of Major Suppliers
  • Germany
  • Major Infectious Disease Diagnostics Market by Assay
  • Germany
  • AIDS Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • CMV Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • EBV Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Gonorrhea Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Hepatitis Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Hepatitis C Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • Germany
  • Herpes Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Influenza Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Meningitis Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Pneumonia Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • RSV Testing Market
  • Estimated Sales by Major Supplier
  • Germany
  • Rotavirus Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Molecular Diagnostics Test Volume And Sales
  • By Major Application
  • Italy
  • Laboratories Performing DNA Sequencing
  • By Market Segment
  • Italy
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Italy
  • Molecular Diagnostics Test Volume
  • By Major Application
  • Italy
  • Major Infectious Disease Test Volume by Assay
  • Italy
  • Major Infectious Disease Test Volume by Method
  • Italy
  • Molecular Diagnostics Market
  • Italy
  • Molecular Diagnostics Market
  • Estimated Sales And Market Shares of Major Suppliers
  • Italy
  • Major Infectious Disease Diagnostics Market by Assay
  • Italy
  • AIDS Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • CMV Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Gonorrhea Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Hepatitis Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Hepatitis C Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • Italy
  • Herpes Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Influenza Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Meningitis Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • Italy
  • RSV Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Molecular Diagnostics Test Volume And Sales
  • By Major Application
  • Spain
  • Laboratories Performing DNA Sequencing
  • By Market Segment
  • Spain
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • Spain
  • Molecular Diagnostics Test Volume
  • By Major Application
  • Spain
  • Major Infectious Disease Test Volume by Assay
  • Spain
  • Major Infectious Disease Test Volume by Method
  • Spain
  • Molecular Diagnostics Market
  • By Major Application
  • Spain
  • Molecular Diagnostics Market
  • Estimated Sales And Market Shares of Major Suppliers
  • Spain
  • Major Infectious Disease Diagnostics Market by Assay
  • Spain
  • AIDS Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Chlamydia Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • CMV Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Gonorrhea Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Hepatitis Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Hepatitis C Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • Spain
  • Herpes Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Influenza Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Meningitis Testing Market
  • Estimated Sales by Major Supplier
  • Spain
  • Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Molecular Diagnostics Test Volume And Sales
  • By Major Application
  • U.K.
  • Laboratories Performing DNA Sequencing
  • By Market Segment
  • U.K.
  • Molecular Diagnostics Market
  • Potential Laboratory Universe by Market Segment
  • U.K.
  • Molecular Diagnostics Test Volume
  • By Major Application
  • U.K.
  • Major Infectious Disease Test Volume by Assay
  • U.K.
  • Major Infectious Disease Test Volume by Method
  • U.K.
  • Molecular Diagnostics Market
  • By Major Application
  • U.K.
  • Molecular Diagnostics Market
  • Estimated Sales And Market Shares of Major Suppliers
  • U.K.
  • Major Infectious Disease Diagnostics Market by Assay
  • U.K.
  • AIDS Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Gonorrhea Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Hepatitis C Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • HIV/Hepatitis Blood Screening NAT Market
  • Reagent Sales by Major Supplier
  • U.K.
  • Influenza Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Mycoplasma Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Pneumonia Testing Market
  • Estimated Sales by Major Supplier
  • U.K.
  • Shigella Testing Market
  • Estimated Sales by Major Supplier
Back to Top